Literature DB >> 11675003

proBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment.

M Fiedler1, A Skerra.   

Abstract

The proline-auxotrophic Escherichia coli K12 strain JM83 harbouring an expression vector providing the proBA gene in trans was utilized for the fermenter production of the partially humanized IN-1 antibody F(ab) fragment. Thus, plasmid-mediated complementation of the chromosomal proBA deletion was employed as a second selection mechanism, together with a chloramphenicol resistance, in order to (i) abolish plasmid loss and (ii) benefit from E. coli JM83 as an expression strain with approved periplasmic protein secretion characteristics in the presence of a minimal medium. Starting from the generic vector pASK75, which makes use of the tightly regulated and chemically inducible tet promoter for foreign gene expression, a set of new vectors carrying the entire or part of the proBA operon was constructed and compared concerning their capability of functional Delta proBA complementation as well as recombinant protein yield. As a result, the vector pMF1 was developed, where transcription of the proBA operon is controlled by its own constitutive promoter and terminator sequences, permitting the transformed JM83 strain to grow under glucose/ammonia minimal culture conditions. When pMF1 was used for the fermenter production of the IN-1 F(ab) fragment, no plasmid loss was observed during the growth and induction phases, and the yield of functionally purified recombinant protein was found to be considerably improved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675003     DOI: 10.1016/s0378-1119(01)00629-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Solubility engineering and crystallization of human apolipoprotein D.

Authors:  Amber Nasreen; Martin Vogt; Hyun Jin Kim; Andreas Eichinger; Arne Skerra
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

Review 2.  Antibiotic-free selection in biotherapeutics: now and forever.

Authors:  Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Pathogens       Date:  2015-04-03

3.  Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.

Authors:  Chee-Mun Fang; Jin Yuan Wang; Magaly Chinchilla; Myron M Levine; William C Blackwelder; James E Galen
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

4.  Optimizing expression of Streptococcus pneumoniae surface protein a, PspA: serocross-reactivity within families of antisera induced against clades 1 and 3.

Authors:  Marcelo Silva; Joaquin Cabrera-Crespo; Maria E Sbrogio-Almeida; Eliane N Miyaji; Paulo L Ho; Luciana C C Leite; Alexandre P Y Lopes
Journal:  Mol Biotechnol       Date:  2007-10       Impact factor: 2.695

5.  Antibiotic-free selection in E. coli: new considerations for optimal design and improved production.

Authors:  Isabelle Peubez; Nicolas Chaudet; Charlotte Mignon; Géraldine Hild; Stéphanie Husson; Virginie Courtois; Karelle De Luca; Denis Speck; Régis Sodoyer
Journal:  Microb Cell Fact       Date:  2010-09-07       Impact factor: 5.328

6.  High-yield production of biologically active recombinant protein in shake flask culture by combination of enzyme-based glucose delivery and increased oxygen transfer.

Authors:  Kaisa Ukkonen; Antti Vasala; Heikki Ojamo; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2011-12-12       Impact factor: 5.328

Review 7.  Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications.

Authors:  Christopher M Whitford; Saskia Dymek; Denise Kerkhoff; Camilla März; Olga Schmidt; Maximilian Edich; Julian Droste; Boas Pucker; Christian Rückert; Jörn Kalinowski
Journal:  J Biol Eng       Date:  2018-08-14       Impact factor: 4.355

8.  Isolation, characterization and heterologous expression of a novel chitosanase from Janthinobacterium sp. strain 4239.

Authors:  Mads G Johnsen; Ole C Hansen; Peter Stougaard
Journal:  Microb Cell Fact       Date:  2010-01-22       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.